News
8/5/2020

InstaCOVID19, a new project to develop rapid diagnostic tests for SARS-CoV-2

InstaCOVID19, a new project to develop rapid diagnostic tests for SARS-CoV-2


News from DCEXS-UPF


The InstaCOVID19 project for the development of rapid tests for detecting SARS-CoV-2 has been launched in the framework of the UPF crowdfunding initiative #UPFContraElCoronavirus, driven by UPFund. Timely or regular donations to help fund the project can be made on the campaign web page.

The project is led by Pilar Rivera Gil, head of the Integrative Biomedical Materials and Nanomedicine Lab Research Group, which is to develop the project with the UPF Innovation Unit, UPF Ventures, and the company Serstech.

"InstaCOVID19 is a diagnostic test that combines the speed of an ELISA test with the reliability of a PCR. One of its great potentials, in addition to its ability to diagnose multiple pathogens in parallel, is that it can be used to perform population screenings. This allows identifying “apparently healthy” individuals who constitute the main factor for the transmission of the virus and are, therefore, a crucial factor to evaluate the evolution of the disease”, Pilar Rivera Gil explains.

 

More information:
DCEXS-UPF website